These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 15183454)

  • 41. Small-molecule screen identifies modulators of EWS/FLI1 target gene expression and cell survival in Ewing's sarcoma.
    Boro A; Prêtre K; Rechfeld F; Thalhammer V; Oesch S; Wachtel M; Schäfer BW; Niggli FK
    Int J Cancer; 2012 Nov; 131(9):2153-64. PubMed ID: 22323082
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic impact of P53 status in Ewing sarcoma.
    de Alava E; Antonescu CR; Panizo A; Leung D; Meyers PA; Huvos AG; Pardo-Mindán FJ; Healey JH; Ladanyi M
    Cancer; 2000 Aug; 89(4):783-92. PubMed ID: 10951341
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phosphorylation of the EWS IQ domain regulates transcriptional activity of the EWS/ATF1 and EWS/FLI1 fusion proteins.
    Olsen RJ; Hinrichs SH
    Oncogene; 2001 Mar; 20(14):1756-64. PubMed ID: 11313922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transforming activity of EWS/FLI is not strictly dependent upon DNA-binding activity.
    Jaishankar S; Zhang J; Roussel MF; Baker SJ
    Oncogene; 1999 Sep; 18(40):5592-7. PubMed ID: 10523836
    [TBL] [Abstract][Full Text] [Related]  

  • 45. EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3.
    Prieur A; Tirode F; Cohen P; Delattre O
    Mol Cell Biol; 2004 Aug; 24(16):7275-83. PubMed ID: 15282325
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The COOH-terminal domain of FLI-1 is necessary for full tumorigenesis and transcriptional modulation by EWS/FLI-1.
    Arvand A; Welford SM; Teitell MA; Denny CT
    Cancer Res; 2001 Jul; 61(13):5311-7. PubMed ID: 11431376
    [TBL] [Abstract][Full Text] [Related]  

  • 47. EWS/FLI1 suppresses retinoblastoma protein function and senescence in Ewing's sarcoma cells.
    Hu HM; Zielinska-Kwiatkowska A; Munro K; Wilcox J; Wu DY; Yang L; Chansky HA
    J Orthop Res; 2008 Jun; 26(6):886-93. PubMed ID: 18271016
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An association between viral genes and human oncogenic alterations: the adenovirus E1A induces the Ewing tumor fusion transcript EWS-FLI1.
    Sanchez-Prieto R; de Alava E; Palomino T; Guinea J; Fernandez V; Cebrian S; LLeonart M; Cabello P; Martin P; San Roman C; Bornstein R; Pardo J; Martinez A; Diaz-Espada F; Barrios Y; Ramon y Cajal S
    Nat Med; 1999 Sep; 5(9):1076-9. PubMed ID: 10470089
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adenovirus E1A does not induce the Ewing tumor-associated gene fusion EWS-FLI1.
    Kovar H; Fallaux FJ; Pribill I; Jugovic D; Bartl S; Ambros PF; Aryee DN; Wiegant JC; Hoeben RC
    Cancer Res; 2000 Mar; 60(6):1557-60. PubMed ID: 10749123
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma.
    Smith R; Owen LA; Trem DJ; Wong JS; Whangbo JS; Golub TR; Lessnick SL
    Cancer Cell; 2006 May; 9(5):405-16. PubMed ID: 16697960
    [TBL] [Abstract][Full Text] [Related]  

  • 51. EWS/FLI mediates transcriptional repression via NKX2.2 during oncogenic transformation in Ewing's sarcoma.
    Owen LA; Kowalewski AA; Lessnick SL
    PLoS One; 2008 Apr; 3(4):e1965. PubMed ID: 18414662
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Advances in Ewing's sarcoma research: where are we now and what lies ahead?
    Ordóñez JL; Osuna D; Herrero D; de Alava E; Madoz-Gúrpide J
    Cancer Res; 2009 Sep; 69(18):7140-50. PubMed ID: 19738075
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Minimal residual disease in bone marrow in patients with Ewing's sarcoma detected by RT-PCR amplification of EWS-FLI-1 fusion gene transcript].
    Tang S; Huang D; Zhang X
    Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):48-9. PubMed ID: 11776597
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interference with the constitutive activation of ERK1 and ERK2 impairs EWS/FLI-1-dependent transformation.
    Silvany RE; Eliazer S; Wolff NC; Ilaria RL
    Oncogene; 2000 Sep; 19(39):4523-30. PubMed ID: 11002425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells.
    Riggi N; Suvà ML; Suvà D; Cironi L; Provero P; Tercier S; Joseph JM; Stehle JC; Baumer K; Kindler V; Stamenkovic I
    Cancer Res; 2008 Apr; 68(7):2176-85. PubMed ID: 18381423
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of target genes in their native cellular context: an analysis of EWS/FLI in Ewing's sarcoma.
    Owen LA; Lessnick SL
    Cell Cycle; 2006 Sep; 5(18):2049-53. PubMed ID: 16969112
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model.
    Takigami I; Ohno T; Kitade Y; Hara A; Nagano A; Kawai G; Saitou M; Matsuhashi A; Yamada K; Shimizu K
    Int J Cancer; 2011 Jan; 128(1):216-26. PubMed ID: 20648560
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein.
    Chansky HA; Hu M; Hickstein DD; Yang L
    Cancer Res; 2001 May; 61(9):3586-90. PubMed ID: 11325824
    [TBL] [Abstract][Full Text] [Related]  

  • 59. EWS-FLI1 inhibits TNFalpha-induced NFkappaB-dependent transcription in Ewing sarcoma cells.
    Lagirand-Cantaloube J; Laud K; Lilienbaum A; Tirode F; Delattre O; Auclair C; Kryszke MH
    Biochem Biophys Res Commun; 2010 Sep; 399(4):705-10. PubMed ID: 20691659
    [TBL] [Abstract][Full Text] [Related]  

  • 60. EWS/FLI and its downstream target NR0B1 interact directly to modulate transcription and oncogenesis in Ewing's sarcoma.
    Kinsey M; Smith R; Iyer AK; McCabe ER; Lessnick SL
    Cancer Res; 2009 Dec; 69(23):9047-55. PubMed ID: 19920188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.